Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the bioequivalence of a Merck clinical trial formulation of
ondansetron compared to a non-U.S. marketed formulation of ondansetron.